Petra Schulz

Title: Petra Schulz: Innovator in Coagulation Factor Research

Introduction

Petra Schulz is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of coagulation factor research, holding a total of six patents. Her work focuses on the development of high-purity preparations and processes that enhance the efficiency of coagulation factors.

Latest Patents

Among her latest patents is the "FX activation process and its use in the preparation of a FXa composition." This invention relates to a high purity Coagulation Factor Xa (FXa) preparation and an activation and purification process that achieves high purity and a high degree of activation without the addition of proteinaceous activators during manufacturing. Another notable patent is the "Process for production of fibrinogen and fibrinogen produced thereby." This process involves purifying fibrinogen from a fibrinogen-containing source by precipitation with a precipitating agent, while utilizing one or more chelating agents. The method allows for the extraction of fibrinogen from the paste, resulting in a liquid fraction containing fibrinogen and an undissolved residue that is separated from the liquid.

Career Highlights

Petra Schulz is currently employed at Octapharma AG, a company known for its innovative approaches in the field of biopharmaceuticals. Her work at Octapharma has positioned her as a key player in the development of advanced therapeutic solutions.

Collaborations

Throughout her career, Petra has collaborated with notable colleagues, including Rainer Pape and Werner Gehringer. These collaborations have further enriched her research and contributed to the advancement of coagulation factor technologies.

Conclusion

Petra Schulz's innovative work in coagulation factor research has led to significant advancements in the field. Her patents reflect her commitment to improving therapeutic processes and outcomes.